CUSIP 90400D108COMRAREQ4 2025
45 filings · latest Feb 5, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Vanguard Group Inc | 10.26M | $236.07M |
| 2 | Blackrock, Inc. | 6.63M | $152.53M |
| 3 | State Street Corp | 4.30M | $98.97M |
| 4 | Jpmorgan Chase & Co | 3.97M | $91.40M |
| 5 | Sands Capital Management, LLC | 3.49M | $80.17M |
| 6 | Rtw Investments, LP | 3.00M | $69.00M |
| 7 | Baker Bros. Advisors LP | 2.77M | $63.77M |
| 8 | Fmr LLC | 2.67M | $61.32M |
| 9 | Wellington Management Group LLP |
| 4 | Feb 12, 2025 | Sands Capital Management, LLC | 13G/A | 4.7% | 4.30M | SEC |
| 5 | Feb 10, 2025 | Wellington Management Group LLP | 13G/A | 2.7% | 2.46M | SEC |
| 6 | Nov 14, 2024 | Rtw Investments, LP | 13G/A | 2.1% | 1.97M | SEC |
| 7 | Feb 14, 2024 | Rtw Investments, LP | 13G/A | 8.4% | 6.89M | SEC |
| 8 | Feb 14, 2024 | Price T Rowe Associates Inc /Md/ | 13G/A | 4.2% | 3.45M | SEC |
| 9 | Feb 13, 2024 | Vanguard Group Inc | 13G/A | 10.6% | 8.67M | SEC |
| 10 | Feb 13, 2024 | Sands Capital Management, LLC | 13G | 5.0% | 4.12M | SEC |
See the full Schedule 13D/13G history for Ultragenyx Pharmaceutical In.
Unlock full history| 2.46M |
| $56.62M |
| 10 | Citadel Advisors LLC | 2.33M | $53.50M |